For Immediate Release

2016.01.28

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Joji Nakayama, Representative Director, President and CEO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Executive Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com/

Daiichi Sankyo Selected for RobecoSAM Industry Mover Sustainability Award 2016

TOKYO, Japan (January 28, 2016) - Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has been selected from among 55 major pharmaceutical companies as the Industry Mover in RobecoSAM AG'sThe Sustainability Yearbook 2016. The Industry Mover is a company with a RobecoSAM Corporate Sustainability Assessment (CSA) score within the top 15% of its industry which has achieved the largest proportional improvement in its sustainability performance compared to the previous year.

Daiichi Sankyo's efforts in Customer Relationship Management, Product Quality and Recall Management and Climate Change Strategy have received high praise. In addition, Codes of Conduct/Compliance/Corruption & Bribery, Environmental Reporting, and Strategy to Improve Access to Drug or Products scored considerably higher than last year as a result of corporate performance related to global codes of conduct, disclosure and external certification of environmental data, and activities that contribute to the health improvement of mothers and children in China.

In 2015, Daiichi Sankyo was also selected for the sixth consecutive year for the Dow Jones Sustainability Asia Pacific Indices (DJSI Asia Pacific), from S&P Dow Jones Indices LLC and SRI*3 evaluation company, RobecoSAM AG.

Daiichi Sankyo will continue to make every effort to fulfill our social responsibility by implementing responsible corporate activities which address sustainability issues appropriately to improve corporate value sustainably and to put into practice its mission, 'To contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals, and through the provision of pharmaceuticals addressing diverse medical needs.'

RobecoSAM AG:

Swiss based investment specialist in focused exclusively on sustainability investing. It offers asset management, indices, engagement, voting, impact analysis, sustainability assessments, and benchmarking services. In addition, together with S&P Dow Jones Indices, Inc., RobecoSAM published the globally recognized Dow Jones Sustainability Indices (DJSI).

The Sustainability Yearbook 2016:

Every year, RobecoSAM evaluates the initiatives and level of informational disclosure of each company in the three categories, the economic, environmental and social, more than 3,000 leading companies around the world, lists the top 15% of companies in 59 industries in The Sustainability Yearbook. In its 2016 publication, 464 companies (including 48 Japanese companies) have been listed. 54 companies in each 54 industries, including Daiichi Sankyo, were selected for Industry Mover, given to companies that achieved the largest proportional improvement in its sustainability performance compared to the previous year.

Socially Responsible Investment (SRI):

An investment based on criteria that assess a company's social responsibility performance from social, ethical and environmental perspectives, in addition to financial analysis.

Industry Mover Logo, given to companies that achieved the largest proportional improvement in its sustainability performance compared to the previous year.

Daiichi Sankyo Co. Ltd. issued this content on 28 January 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 28 January 2016 05:23:16 UTC

Original Document: http://www.daiichisankyo.com/media_investors/media_relations/press_releases/detail/006398.html